Health Trials

Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin

Participants needed: 36
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Feb 4, 2026Locations: 1
Eligibility criteria

Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]

Those who have clinical significant liver, kidney, nervous system, respiratory,...

Read more
Status: Not yet recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1

Participants needed: 38
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Jan 23, 2026Locations: 1
Eligibility criteria

Healthy adult aged 19 to 50 (inclusive) years [+1]

clinical significant liver, kidney, nervous system, respiratory, endocrine, hema...

Read more
Status: Not yet recruiting

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.

Participants needed: 48
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Jan 20, 2026Locations: 1
Eligibility criteria

Healthy adult volunteers aged 19 years or older at the time of screening [+1]

Those with a current or past medical history of clinically significant liver, ki...

Read more
Status: Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs

Participants needed: 150
Trial details
Phase: Phase 1Age: 19-50Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Jan 15, 2026Locations: 1
Eligibility criteria

Healthy adult aged 19 to 50 (inclusive) years, at the time of screening. [+1]

Those who have clinical significant liver, kidney, nervous system, respiratory,...

Read more
Status: Recruiting

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

This study aims to compare the efficacy and safety of DW1807 and DW1807-R2 in patients with perennial allergic rhinitis and comorbid asthma. The primary objective is to demonstrate the superiority of DW1807 over DW1807-R2 in improving the reflective total nasal symptom score (rTNSS) after 4 weeks of treatment.

Participants needed: 274
Trial details
Phase: Phase 3Age: 19+Biological sex: AllType: InterventionalSponsor: Daewon Pharmaceutical Co., Ltd.Updated: Sep 11, 2025Locations: 1
Eligibility criteria

Male or female adults aged 19 years or older. [+6]

Individuals diagnosed with non-allergic rhinitis of other causes. [+10]

Read more